User:Pradaxacost

The usefulness of pradaxa be priced was studied in two randomized, double-blind, parallel group trials involving almost 5600 sufferers undergoing knee or hip replacement surgical treatment. The sufferers received 150 or 220 mg dabigatran etexilate after every day orally or 40 mg enoxaparin subcutaneously. The main endpoint was the blend of just about every with the complete number of venous thromboembolism (VTE) and total mortality, a secondary endpoint was the composite of key VTE and VTE-related mortality. [3] In each scientific studies, dabigatran etexilate as successful as enoxaparin with respect to the prevention of clot formation or to avoid death: